202 related articles for article (PubMed ID: 24311627)
21. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy.
Kumar A; Kaundal RK; Iyer S; Sharma SS
Life Sci; 2007 Mar; 80(13):1236-44. PubMed ID: 17289084
[TBL] [Abstract][Full Text] [Related]
22. Diphenyl diselenide alleviates diabetic peripheral neuropathy in rats with streptozotocin-induced diabetes by modulating oxidative stress.
Wang X; Huan Y; Li C; Cao H; Sun S; Lei L; Liu Q; Liu S; Ji W; Liu H; Huang K; Zhou J; Shen Z
Biochem Pharmacol; 2020 Dec; 182():114221. PubMed ID: 32949583
[TBL] [Abstract][Full Text] [Related]
23. Autophagy and anti-inflammation ameliorate diabetic neuropathy with Rilmenidine.
Yalçın MB; Bora ES; Çakır A; Akbulut S; Erbaş O
Acta Cir Bras; 2023; 38():e387823. PubMed ID: 38055406
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin E1 Protects the Peripheral Nerve in Diabetics through Preventing Vascular Permeability Changes.
Mo F; Hu G; Liu W; He L; Wang H
Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):113-122. PubMed ID: 28954306
[TBL] [Abstract][Full Text] [Related]
25. Protective effect of gliclazide on diabetic peripheral neuropathy through Drp-1 mediated-oxidative stress and apoptosis.
Wu YB; Shi LL; Wu YJ; Xu WH; Wang L; Ren MS
Neurosci Lett; 2012 Aug; 523(1):45-9. PubMed ID: 22732450
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy.
Giatti S; Pesaresi M; Cavaletti G; Bianchi R; Carozzi V; Lombardi R; Maschi O; Lauria G; Garcia-Segura LM; Caruso D; Melcangi RC
Neuroscience; 2009 Dec; 164(2):520-9. PubMed ID: 19665520
[TBL] [Abstract][Full Text] [Related]
27. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
Saini AK; Kumar H S A; Sharma SS
Eur J Pharmacol; 2007 Jul; 568(1-3):164-72. PubMed ID: 17521626
[TBL] [Abstract][Full Text] [Related]
28. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy.
Hellweg R; Hartung HD
J Neurosci Res; 1990 Jun; 26(2):258-67. PubMed ID: 2142224
[TBL] [Abstract][Full Text] [Related]
29. Comparison of sensory tests and neuronal quantity of peripheral nerves between streptozotocin (STZ)-induced diabetic rats and paclitaxel (PAC)-treated rats.
Jin HY; Lee NY; Ko HA; Lee KA; Park TS
Somatosens Mot Res; 2016; 33(3-4):186-195. PubMed ID: 27756190
[TBL] [Abstract][Full Text] [Related]
30. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Sayyed SG; Kumar A; Sharma SS
Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090
[TBL] [Abstract][Full Text] [Related]
31. Improved neural microcirculation and regeneration after peripheral nerve decompression in DPN rats.
Zhong W; Yang M; Zhang W; Visocchi M; Chen X; Liao C
Neurol Res; 2017 Apr; 39(4):285-291. PubMed ID: 28290778
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective effect of cerium oxide nanoparticles in a rat model of experimental diabetic neuropathy.
Najafi R; Hosseini A; Ghaznavi H; Mehrzadi S; Sharifi AM
Brain Res Bull; 2017 May; 131():117-122. PubMed ID: 28373151
[TBL] [Abstract][Full Text] [Related]
33. Protective and therapeutic effects of swimming exercise training on diabetic peripheral neuropathy of streptozotocin-induced diabetic rats.
Selagzi H; Buyukakilli B; Cimen B; Yilmaz N; Erdogan S
J Endocrinol Invest; 2008 Nov; 31(11):971-8. PubMed ID: 19169052
[TBL] [Abstract][Full Text] [Related]
34. Protection of insulin‑like growth factor 1 on experimental peripheral neuropathy in diabetic mice.
Wang H; Zhang H; Cao F; Lu J; Tang J; Li H; Zhang Y; Feng B; Tang Z
Mol Med Rep; 2018 Nov; 18(5):4577-4586. PubMed ID: 30221656
[TBL] [Abstract][Full Text] [Related]
35. The preventive efficacy of methylcobalamin on rat peripheral neuropathy influenced by diabetes via neural IGF-1 levels.
Jian-bo L; Cheng-ya W; Jia-wei C; Xiao-lu L; Zhen-qing F; Hong-tai M
Nutr Neurosci; 2010 Apr; 13(2):79-86. PubMed ID: 20406575
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotective effect of diosgenin in a mouse model of diabetic peripheral neuropathy involves the Nrf2/HO-1 pathway.
Leng J; Li X; Tian H; Liu C; Guo Y; Zhang S; Chu Y; Li J; Wang Y; Zhang L
BMC Complement Med Ther; 2020 Apr; 20(1):126. PubMed ID: 32336289
[TBL] [Abstract][Full Text] [Related]
37. [Amelioration effect of Zhenqing Capsule on peripheral neuropathy in type 1 diabetic rats].
Wen XY; Hu QJ; Wang F
Zhong Xi Yi Jie He Xue Bao; 2008 Mar; 6(3):289-93. PubMed ID: 18334151
[TBL] [Abstract][Full Text] [Related]
38. Microvessel permeability correlates with diabetic peripheral neuropathy in early stage of streptozotocin-induced diabetes rats.
Peng L; Liu W; Zhai F; He L; Wang H
J Diabetes Complications; 2015; 29(7):865-71. PubMed ID: 26150384
[TBL] [Abstract][Full Text] [Related]
39. Trimetazidine provides protection against diabetic polyneuropathy in rats via modulation of soluble HMGB1.
Gölboyu BE; Erdoğan MA; Erbaş O
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5854-5861. PubMed ID: 37401322
[TBL] [Abstract][Full Text] [Related]
40. Curcumin Ameliorates the Experimental Diabetic Peripheral Neuropathy through Promotion of NGF Expression in Rats.
Zhang WX; Lin ZQ; Sun AL; Shi YY; Hong QX; Zhao GF
Chem Biodivers; 2022 Jun; 19(6):e202200029. PubMed ID: 35538560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
